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SUMMARY
Chromosomal integrity has been known for many years to affect the ability of mouse embryonic stem cells (mESCs) to contribute to the
germline of chimeric mice. Abnormal chromosomes are generally detected by standard cytogenetic karyotyping. However, this method is
expensive, time consuming, and often omitted prior to blastocyst injection, consequently reducing the frequency of mESC-derived
offspring. Here, we show a fast, accurate, and inexpensive screen for identifying the two most common aneuploidies (Trisomy 8 and
loss of chromosome Y) in genetically manipulated mESCs using quantitative real-time PCR (qPCR). Screening against these two
aneuploidies significantly increases the fraction of normal mESC clones. Our method is extremely sensitive and can detect as low as
10% aneuploidy among a large population of mESCs. It greatly expedites the generation of mutant mice and provides a quick tool for
assessing the aneuploidy percentages of any mESC line.

INTRODUCTION
Techniques for manipulating genes in the germline of
experimental mammals provide a powerful means to
study the pathophysiology of human disease (Misra and
Duncan, 2002). Genes can be altered or introduced by
the genetic manipulation of embryonic stem cells (ESCs).
ESCs, derived from the inner cell mass of blastocysts, can
contribute to all embryonic tissues, including the germ
cells of developing mice. ‘‘Gene targeting’’ of a specific
genetic locus in ESCs has been a staple in the field of
genetic manipulation for the last 20 years. Mutations are
introduced through homologous recombination by endogenous mechanisms, by TALENs, or by CRISPR/Cas9 (Capecchi, 2005; Mussolino and Cathomen, 2012; Wang et al.,
2013; Zhang et al., 2011). Genetically manipulated ESCs
are subsequently injected into wild-type blastocysts, which
are then surgically transferred to a pseudopregnant surrogate mother to generate chimeric mice that are able to
transmit the mutant genetic locus to their progeny. Recent
advances allow genetically modified ESCs to be injected
immediately into eight-cell embryos, and, when F0 mice
are produced, 100% germline transmission efficiency ensues. Either procedure requires that ESCs follow the correct
developmental program and contribute to the germline
(Liu et al., 1997). However, ESCs often have a low efficiency
of germline transmission. It has been shown that mouse
ESC (mESC) lines carrying three copies of chromosome 8
(chr8), i.e., Trisomy 8, have a higher growth rate and a
diminished efficiency of contribution to the germline as
observed in 19/29 karyotyped ESCs (Liu et al., 1997). A
comprehensive analysis of mESC clones in Japan revealed

only 66% of 540 mESC clones contained normal chromosome counts. When a subset of 88 mESC clones was further
analyzed, 40% (35 mESCs) of them contained chromosomal aneuploidy with 34/35 having aneuploidy containing either chr8 and/or chrY (Sugawara et al., 2006). A recent
study, in which 97 mESC lines were analyzed using conventional cytogenetic analysis and fluorescent in situ hybridization (FISH), showed that chromosomal aneuploidy
occurs in 32% (31) of the specimens with 30/31 containing
either chr8 and/or chrY (Kim et al., 2013). Aneuploidy for
all other chromosomes was almost always associated with
chr8 and/or chrY (83/85 mESC clones). Only in two cases
out of 214 (29+88+97) total analyzed mESC clones, a trisomy was identified (chr11) that did not contain either
chr8 and/or chrY. In sum, removal of 39% (83/214) of
potentially detrimental mESC clones by karyotype analysis
is crucial before injecting modified mESCs into blastocysts.
Unfortunately, existing cytogenetic karyotyping
methods are labor intensive, requiring at least 15 fixed
metaphase preparations, subsequent DAPI staining, and
analysis with an epi-fluorescence microscope equipped
with specialized digital imaging software. Conventional
karyotyping is expensive ($400/clone) and often needs
to be outsourced to specialized core facilities. Therefore,
we designed a simple, fast, and cost-effective ($1/clone)
SYBR-Green-I-based qPCR procedure to identify common
chromosomal aneuploidies found in genetically manipulated mESCs. In contrast to regular PCR, qPCR combines
PCR amplification and detection into a single step using
detection chemistries such as target-specific hydrolysis
probes and SYBR Green I dye, which binds double-stranded
DNA and emits fluorescence only when bound. To date,
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qPCR is the benchmark for gene expression analysis, but
recent developments also encourage the use of qPCR for
copy number determination (D’haene et al., 2010b). In
this regard, qPCR is currently used for diagnostic copy
number profiling of the SHOX gene region in idiopathic
short stature (ISS) and allied disorders (D’haene et al.,
2010a). In addition, it has been shown to be an elegant
tool to accurately screen for correctly targeted mESC clones
(using the so-called loss-of-allele assay or LOA) (Frendewey
et al., 2010) and for genotyping of gene-targeted and transgenic mice (Haurogné et al., 2007; Sakurai et al., 2008).
These studies show that qPCR can be applied to discriminate 2-fold differences in the copy number of a specific
transgene, allowing discrimination between homozygous
and hemizygous transgenic animals. We have applied
and optimized this method to discriminate among chromosomal aneuploidies, ranging from loss of a chromosome
to extra copies of a particular chromosome of interest.
The accumulation of fluorescent signal during the exponential phase of a PCR results in a fast, precise quantification of PCR products and allows for objective data analysis.
The quantification cycle or Cq value represents the fractional PCR cycle that is characteristic for the amplification
curve (e.g., where increase in fluorescence is maximum)
or at which the fluorescence crosses a certain threshold
(D’haene et al., 2010b). Cq value and initial amount of
input DNA are inversely related: a sample that contains
more copies of template will cross the threshold at an
earlier cycle compared to one containing fewer copies of
template (Schmittgen et al., 2000). Consequently, the theoretical difference in Cq (dCq) between two and three copies
of an autosome is about a half cycle, whereas the dCq
between one and two copies is one cycle. With 53 mESC
lines (all male), we were able to validate the sensitivity
and accuracy of our approach in great detail, which
resulted in a quick and user-friendly paradigm to test the
quality of any genetically manipulated mESC clone in
less than 1 day. We confirmed our approach with the two
most common chromosome aneuploidies found in mESCs:
chr8 and chrY, and we further validated the approach with
rare chr11 and partial chr1 aneuploidies among our collection of cytogenetically karyotyped clones.

RESULTS
Extensive Karyotyping of 141 ESC Clones
A large karyotyping project in our lab revealed that out of
141 mESC lines analyzed with conventional DAPI-band
karyotyping, 48.2% of the clones (68 total) were ‘‘normal’’
and do not contain chromosomal breakage or low mitotic
index; 51.8% of the clones (73 in total) had chromosomal
abnormalities including Trisomy 8 (24.8%), loss of chrY

(9.2%), both Trisomy 8 and 11 (2.1%), both Trisomy 8 and
an extra copy of chrY (0.7%), and other structural abnormalities (14.2%). Overall, our data revealed that 38% (53/141)
of mESC clones contained either chr8 and/or chrY aneuploidy (Table S1 available online) consistent with data
reported in the literature (Kim et al., 2013; Liu et al., 1997;
Sugawara et al., 2006). Only 1/141 mESC clones (ESC 8)
contained a trisomy that did not also contain chr8 and/or
chrY (31% of ESC 8 cells contained an extra chr1). The overall rate derived from the three published studies and our
study suggests that non-chr8 and/or non-chrYaneuploidies
appear at an equal or lower rate than 3/355 mESC clones
(0.84%). Two anomalies that cannot be identified by any
method other than cytogenetic karyotyping (chromosomal
breakage and low mitotic index) occurred in 4/141 ESC
clones (2.8%). Thus, chr8 and chrY aneuploidies are by far
the most common cytogenetic anomalies identified.
Quantitative Real-Time PCR Using SYBR Green I Dye
We set up a qPCR approach to identify the most common
aneuploidies (chr8 and chrY) and the rare aneuploidies
(chr1 and chr11) using two chromosomes without aneuploidy (chr7 and chrX), which serve as our references.
DNA isolated from 53 mESC lines is utilized in the qPCR
validation experiments (Table 1). We use the SYBR Green I
dye as the fluorogenic marker to keep the method simple
and easily applicable for any lab. Hydrolysis probes, at
considerable costs, may also function; however, our
approach requires only one well-designed and characterized primer set per target chromosome and no sequencespecific probe, significantly reducing assay setup. For the
qPCR, we designed primers that specifically generate exonic
amplicons located on mouse chr1 (olfr16), chr7 (omp), chr8
(olfr370), chr11 (olfr1), chrX (obp1a), and chrY (sry) and
extensively validated them in silico and empirically
according to the latest Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE)
guidelines (Bustin et al., 2009) (Table 2). Intronic region amplicons, with reduced genomic complexity, gave inconsistent results (data not shown) and were avoided. To increase
PCR efficiency and accessibility of the genomic DNA, we digested all mESC DNA with restriction endonucleases before
qPCR screening, reducing the genomic DNA (gDNA) viscosity. All samples were run in triplicate, and the average Cq
value per sample was used in the calculations. The absolute
average of the difference between the triplicate Cq values of
all our samples was 0.0732 ± 0.0737. If any absolute Cq difference (jdCqj) was greater than 0.2206 (i.e., 0.0732 + 2 SDs)
between triplicates, then this PCR was repeated.
Data Analysis Using the 2ddCq Method
Our assay uses relative quantification to calculate the target
chromosome copy number by the so-called comparative
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Table 1. Cytogenetic Karyotypes of Mouse ESC Lines Used for
qPCR
Cell Line

ISCN

Cell Line

ESC 3

40,XY [15]

ESC 1

41,XY,+8 [15]

ESC 5

40,XY [14]

ESC 2

41,XY,+8 [15]

ESC 19a

40,XY [15]

ESC 4

41,XY,+8 [15]

ESC 24

40,XY [14]

ESC 7

41,XY,+8 [15]

ESC 25

40,XY [14]

ESC 9

41,XY,+8 [15]

ESC 31a

40,XY [12]

ESC 20

41,XY,+8 [14]

ESC 32

40,XY [13]

ESC 27

41,XY,+8 [13]

Normal

ESC 33

ISCN

Trisomy 8

40,XY [15]

ESC 28

41,XY,+8 [14]

ESC 52

a

40,XY [14]

ESC 29

41,XY,+8 [15]

ESC 53

a

40,XY [15]

ESC 30

41,XY,+8 [15]

ESC 54a

40,XY [15]

ESC 51

41,XY,+8 [13]

31% Trisomy 1

Trisomy 8 and Extra chrY

ESC8b

ESC12

See Table S1

Loss Of chrY

42,XYY,+8 [15]

Trisomy 8 and 11

ESC 10

39,X,-Y [15]

ESC 13

42,XY,+8,+11 [14]

ESC 14

39,X,-Y [15]

ESC 16

42,XY,+8,+11 [13]

ESC 15

39,X,-Y [14]

ESC 18

42,XY,+8,+11 [15]

ESC 17

3839,X,-Y [16]

ESC 21

39,X,-Y [15]

ESC 22

39,X,-Y [15]

ESC 23

39,X,-Y [14]

The following lines had unknown cytogenetic karyotypes and were used to
validate our qPCR approach: ESC 6, ESC 11, and ESC 34–ESC 50. Karyotypes of
lines ESC 40, ESC 45, and ESC 48 were confirmed by DAPI-banded karyotyping
after obtaining the qPCR results. Karyotypes were the following: ESC 40,
3740,XY[20]; ESC 45, 3839,X,-Y[15]/40,XY[1]; ESC48, 3940,XY[15].
See also Table S1.
a
These cell lines produced germline animals.
b
ESC8 is of mixed genetic background and was derived in the lab.

Cq method or 2ddCq method (Pfaffl, 2001; Schmittgen
et al., 2000). This method compares the Cq value of one
target gene to another internal control or reference gene
from a single sample. We chose genes on chr7 (omp) and
chrX (obp1a) as reference genes because no aneuploidy
was detected for either in any of our 141 karyotyped male
mESCs. For the comparative Cq method to be valid, the
amplification efficiency of the target and the reference
genes must be approximately equal. The amplification efficiencies of each of the primer sets was determined based

upon the generation of standard curves using gDNA
dilution series and for all primer sets analyzed the PCR
efficiencies ranged between 95% and 120% (Figure S2).
For the initial calibration of our data, we used three calibrator mESC lines with previously determined, normal
cytogenetic karyotypes, which produced germline animals
(ESC 31, 52, and 53). We had numerous germline animals
produced from mESCs and chose three to calculate an
average normalized relative quantity (NRQ). Theoretically,
only one calibrator is required for accurate analysis of
the data. In the case that no such lines are readily available
in the lab, mESCs with a normal cytogenetic karyotype
are commercially available (http://www.atcc.org/). After
initial screening of mESCs using this qPCR method, additional calibrators can be identified and added to future
analyses.
The final NRQ value is presented as the fold change in
gene copy number normalized to an endogenous reference
gene (omp on chr7 or obp1A on chrX) and relative to one
or more samples of known karyotype, the calibrators
(Sakurai et al., 2008). For example, a cell line with a normal
karyotype has a final NRQ that is approximately 1
(including our calibrator), whereas loss of chrY-cells
results in a NRQ of approximately 0 (for the sry gene) and
Trisomy 8 or 11 cells show a NRQ of 1.5 (for olfr370 or
olfr1, respectively). We tested our method by calculating
the NRQ value for chr8 (olfr370), chr11 (olfr1), and chrY
(sry) in 34 ESC lines with known cytogenetic karyotypes
and normalized the results against the NRQ value for
our reference genes chr7 (omp) and chrX (obp1a), see
Experimental Procedures. To obtain the absolute copy
number for each of the chromosomes of interest, the
following formula (Frendewey et al., 2010) was applied
(Figures 1, S1A, and S1B):
Copy number = calibrator copy number X NRQ:
The Interchromosomal SD
In order for this method to be readily applicable in any lab,
we defined a standardized confidence level to assess aneuploidy of any given mESC clone. This cutoff level is mathematically imposed by the relative differences between Cq
values, not likely to vary between labs or instruments. A
sample is considered to be ‘‘normal’’ (normal chromosomal
count) when the NRQ values for chr8, chr11, and chrY are
all approximately 1. If any value becomes significantly
greater or smaller than 1, then aneuploidy is present. We
further defined this divergence away from 1 by determining the likelihood that an mESC clone had significant
NRQ values greater or less than 1. An interchromosomal
SD (IC SD) was derived by determining the SD between
the NRQs of each amplicon for the different chromosomes
within each ESC clone (with the NRQ for our reference
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Table 2. In Silico and Empirical Evaluation of the qPCR Primer Setsa
Standard Curve
Chr

Location

Gene

Primers (50 -30 )

Amplicon
Length (bp)

1

172956826–
172956929

olfr16

GAGTTCGTCTTCCTGGGATTC

103

8651

2.904

120

0.997

0.84–13.5

0.09b

98145342–
98145482

omp

140

8652

2.907

120

0.997

0.84–13.5

0.07

83541895–
83542057

olfr370

162

8653

3.137

108

0.999

0.84–13.5

0.08

73395777–
73395941

olfr1

164

8654

3.439

95

0.996

0.84–13.5

0.02

78085543–
78085693

obp1a

150

8655

2.994

115

0.994

0.84–13.5

0.15

2663266–
2663432

sry

166

8656

3.235

103

0.985

0.84–13.50

0.28c

7

8

11

X

Y

RTprimerDB
ID

Slope

E (%)

r2

Linear Dynamic
Range (ng)

LOD (ng)

TAATGATGTTGCCAGCCAGA
GCCCACTTGATTCCCTGA
GCATCTGCTGGGTCAGGTCC
CACTATGGATGTGCCTCTTTTATCT
TACCCTATGAAGAGCTGATTTGAAG
TCTATGCCCTGTTCCTGGTC
CAACTTGGGCATTGTGACAG
GGATCAGAATTATGGATCATGTG
GATCATGAGAAGGGGAAGGA
CTCATCGGAGGGCTAAAGTG
AAGCTTTGCTGGTTTTTGGA

See also Figure S2.
MIQE guidelines compliant.
b
A LOD of 0.09 ng refers to about 150 cells when screening for autosomes.
c
A LOD of 0.28 ng refers to about 1,000 cells when screening for sex chromosomes (XO or XY).
a

chromosomes 7 and X being ‘‘1’’). To identify an acceptable
IC SD, we used 11 ‘‘normal’’ mESC lines to calculate a 95%
confidence level (or cutoff line) for any mESC clone to be
defined as normal. This cutoff line was derived by averaging the IC SD for the 11 normal ESC lines and adding
twice its SD. This [AVG IC SD + 2 3 SD (IC SD)] =
0.0455 + 2 3 0.0226, which equals 0.0906, can be used to
assess all mESCs (Figure 2). We confirmed all previously
identified chr8, chr11, and chrY aneuploidies using our
screening method (Figure 1, left of dotted line) and validated the anomalous IC SD (Figure 2, above dotted line)
of their respective ESC clones. A more stringent cutoff
would be the [AVG IC SD + 1 3 SD (IC SD)], which equals
0.0681. All mESC clones that generated germline animals
(ESC 19, 31, 52, 53, and 54) show IC SD below this stringent cutoff (Figure 2, green bars).
We further validated this method using 19 additional
mESC lines with unknown cytogenetic karyotypes. We
identified 15 normal mESC lines, one loss of chrY (ESC
45) and two Trisomy 8 (ESC 49, 50) (Figure 1, right of dotted
line, and Figure 2, below dotted line). We confirmed the
cytogenetic karyotypes of ESC 48 (normal) and ESC 45
(loss of chrY) using conventional DAPI banding (Table 1).
ESC 40 consistently yielded IC SDs >0.0906 (Figure 2)
and subsequent cytogenetic karyotyping revealed chromosomal aberrations in 20% of the cells (Table S1).

Detection of Low-Percentage Chromosomal
Imbalances
To determine the limits of the aneuploidy detection by our
method, we created mixtures between the normal line ESC
31 and the robust Trisomy 8 line ESC 9 or the loss of chrY
line ESC 21. The NRQ values were determined for mixtures
with 0%, 5%, 10%, 15%, 20%, 40%, 60%, 80%, and 100%
loss of chrY or Trisomy 8 (Figures 3A and 3B). The IC SD
values show detectable chromosomal imbalances for 10%
mixtures and above for both chr8 and chrY (Figure 3C).
Thus, our data suggest that 10% Trisomy 8 or loss of chrY
is the limit of detection in our qPCR assay. However, using
our most stringent IC SD cutoff, mESC clones with 5%
Trisomy 8 would be discarded.

DISCUSSION
We are able to rapidly identify the common Trisomy 8 and
chrY aneuploidies as well as the rare Trisomy 11 and partial
Trisomy 1 aneuploidies in mESCs. Conventional cytogenetic karyotyping requires direct inspection of chromosomal images through human visual interpretation. The
SYBR Green qPCR-based assay is numerical with fixed
confidence levels and not dependent on such subjectivity
(Frendewey et al., 2010). Our method provides a
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Figure 1. Normalized Chromosome Copy Numbers
The absolute copy number for the autosomes is calculated by multiplying the NRQ values by 2 according to this formula: Copy number =
calibrator copy number X NRQ or (2ddCq). A copy number of 2 reflects normal autosome ploidy, and a copy number of 3 reflects trisomy. The
absolute copy number of chromosome Y equals the NRQ value. A copy number of 1 reflects normal ploidy, a copy number of 0 reflects loss of
chrY, and a copy number of 2 reflects duplication of chrY. A dotted line marks the border between mESCs with previously determined
(known) and unknown karyotypes at the time of qPCR analysis. See also Figure S1.
standardized cutoff IC SD of 0.0906 by which all mESC
lines can be determined as ‘‘normal.’’ This number might
vary slightly, but will not exceed 0.1.
Using a set of 141 karyotyped gene-targeted mESC
clones, we found that 50% (73 clones) contain abnormal
cytogenetic karyotypes that might preclude them from
usage in blastocyst injections and prevent the production
of germline mutations. From this set of 73 clones, 73%
(53) contained aneuploidies of which Trisomy 8 was the
most frequent (39/53). The chromosome Y (chrY) aneuploidies (14/53, either loss or gain) were the only other
consistent chromosomal aneuploidy identified in our
study. ChrY aneuploidies generate (male) mESCs unable
to contribute to the germline of male chimeric animals
and thus progeny cannot be obtained. The germ cells of
male chimeras are typically used to autoexcise a selectable
marker cassette. Removal of the selectable marker in a
mutation is mandatory because it interferes with gene
expression of the surrounding genomic locus.
A cumulative analysis of cytogenetic karyotyping from
four groups, including ours, reveals that out of 355 mESC
clones only 2 (0.5%) contained Trisomy 11 without accompanying aneuploidies (Liu et al., 1997; Sugawara et al.,
2006). In our study, Trisomy 11 only occurred in the pres-

ence of Trisomy 8 (ESC 13, 16, 18). Therefore, screening
for Trisomy 11 aneuploidy is redundant. In addition, these
findings are consistent with our single ESC clone containing
31% Trisomy 1 cells without accompanying aneuploidies
(ESC 8). In order to identify this 31% Trisomy 1 frequency
in ESC 8, we had to cytogenetically karyotype 54 cells (Table
S1). To confirm these data, we screened for partial Trisomy 1
with primers to olfr16 (located on chr1, Table 2) and show a
NRQ value of 1.4, which represents an absolute chr1 copy
number of 2.8 (data not shown), similar to where the NRQ
value would lay for a 30% Trisomy 8 (Figure 3A). Our
method is straightforward, and the Trisomy 1 data show
the ease of adding extra primer sets to the analysis if necessary. In addition, the IC SD for ESC 8 including the chr1
analysis was 0.1699, which is greater than our cutoff of
0.0906, and clearly identifies aneuploidy. Importantly,
adding the NRQ values for chr1 to the IC SD calculation
for the calibrators (ESC 31, ESC 52, and ESC 53) maintained
their IC SD values below 0.05 (data not shown).
Using our screening, we were able to confirm the previously determined cytogenetic karyotypes of 34 mESC lines
and to further validate our method using 19 additional
mESC lines with unknown cytogenetic karyotypes. Our
study includes the screening of five mESC lines that
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produced germline transmission (ESC 19, 31, 52, 53, and
54), all with an IC SD ranging from 0.0268 to 0.0401, well
below our determined cutoff value. Consequently, we
believe that the smaller an IC SD value, the greater the likelihood of the mESC line being passaged through the germline. Using mixtures of a normal mESC line with mESC lines
containing Trisomy 8 or loss of chrY, we show that our
method is able to detect chromosomal imbalances as low
as 10% aneuploidy. By contrast, standard cytogenetic karyotyping requires analysis of 29–31 cells to detect 10%
aneuploidy or 59–73 cells to detect 5% aneuploidy with a
95% confidence level (Hook, 1977); far fewer (15–20 cells)
are usually analyzed by a standard cytogenetic core facility.
In this regard, ESC 24 shows a borderline IC SD of 0.0912,
yet the line gave a normal cytogenetic karyotype when 14
cells were analyzed (Table 1). Based on our method, this
clone would be excluded from blastocyst injection because
the elevated IC SD may reflect low-percentage aneuploidies.
Many laboratories are exploring reprogramming of
somatic cells into induced pluripotent stem cells (iPSCs)
used for drug and disease modeling and directed differentiation experiments. It was previously shown that 75%
of iPSC lines contain aberrant cytogenetic karyotypes
(Boland et al., 2009; Chen et al., 2011). We have tested
our method on one mouse iPSC line with results consistent to cytogenetic karyotyping (data not shown). It
has not escaped our attention that this qPCR-based
method will significantly reduce the number of iPSC lines
requiring cytogenetic karyotyping, greatly reducing costs.
In addition, it lays the groundwork for assessing the
aneuploidy while passaging mouse iPSC lines, not usually
done because of the costs involved in karyotyping
numerous iPSC cell lines.
A similar qPCR-based method for comprehensive chromosomal aneuploidy screening of human blastocysts has
recently been shown to improve the success of in vitro
fertilization (Treff and Scott, 2013). Although these data
demonstrate that the qPCR technology is capable of fast
and accurate screening of all 24 human chromosomes,
the technique is not readily applicable to mouse ESCs or
iPSCs. In contrast, our approach is (1) simple: only one
carefully designed primer set per chromosome is required,
and all primers are available to the scientific community
(RTPrimerDB IDs are shown in Table 2); (2) cost effective:
SYBR Green I is used as the fluorescent dye instead of
gene-specific hydrolysis probes, which would increase the
cost of the screen tremendously; (3) standardized: we provide a cutoff level by which any clone can be assessed;
and (4) sensitive: our technique is able to detect slight percentage differences in aneuploidies. Finally, our method
has proved to be robust, as the three controls that were
included were shown to be true: (1) interrun Cq differences
for the same sample are smaller than the average jdCqj be-

tween triplicates, not requiring interrun calibration and
again simplifying data analysis; (2) independent restriction
endonuclease digests for the same DNA sample yield
similar IC SD values (ESC 12a and b and ESC 31a and b, Figure 2); and (3) subsequent passages for a given ESC line
yield similar NRQ and IC SD values (ESC 49 and 50 and
ESC 7 and 9).
In conclusion, our method is fast and extremely inexpensive and will greatly expedite many researchers’ work in
generating mESC germline transmission. Furthermore, it
is of broad interest to every scientist using genetically
modified mice because mESC clones that will produce
germline animals can be readily identified.

EXPERIMENTAL PROCEDURES
This study is written according to the Minimum Information for
Publication of Quantitative Real-Time PCR Experiments guidelines
(MIQE) to ensure its technical qualities and to allow for correct
interpretation and repeatability (Bustin et al., 2009; D’haene
et al., 2010a). A MIQE compliance checklist is available in the
Supplemental Information (Table S2).

Cytogenetic Karyotyping of Mouse Embryonic Stem
Cell Lines
Subconfluent cultures were treated with 0.05 mg/ml Colcemid
(Karyomax, Invitrogen) for 30–40 min before harvesting according
to standard cytogenetics procedures. Briefly, cells were trypsinized
(0.025% Trypsin: EDTA, EMD Millipore) to a single-cell suspension,
pelleted at 180 3 g for 8 min, and resuspended in warm 0.075M
KCl. After 8 min incubation at 37 C, approximately 1/4 volume
of 3:1 methanol/glacial acetic acid fixative was added and gently
mixed, and the cells were pelleted as before. The cells were then
fixed in three changes of fixative. Fixed cell suspensions were stored
at 20 C. Fixed metaphase preparations were dropped onto dry
slides, and the quality of spreading was assessed by phase microscopy. Slides were then air-dried and aged (at 37 C for several
days, or at 60 C for several hours). Aged slides were immersed in
0.08 mg/ml DAPI in 2 3 saline sodium citrate for 3 min, rinsed,
air-dried, and then mounted in antifade solution (Vectashield,
Vector Laboratories) and stored at 4 C. DAPI-stained slides were
scanned using a Nikon E800 epi-fluorescence microscope equipped
with a digital imaging system (Applied Spectral Imaging). Metaphase images were inverted to resemble conventional G-banding
and karyotyped using BandView software (ASI). Where possible, a
minimum of 15 metaphases was examined for each sample. All
metaphases were fully karyotyped. To avoid confusion, abnormal
karyotypes were described according to the International System
for Human Cytogenetic Nomenclature (ISCN), rather than the
Standardized Genetic Nomenclature for Mice, because the experimental systems are intended to model human disease.

Tissue Culture and Genomic DNA Preparation
Gene-targeted mESC lines from 13 different electroporations (into
E14 parental ESC line, 129ola) grown on a 4 cm2 growth area (Gene
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Figure 3. Detection of Low-Percentage Chromosomal Imbalances
Normalized chromosome copy numbers for percentage changes in chromosome 8 (A), chromosome Y (B), and corresponding IC SD values
(C). To obtain a gradual decrease in loss of chrY or a gradual increase in chr8, we mixed appropriate volumes of a normal control and
calibrator (ESC 31) with a 100% loss of chrY cell line (ESC 21) or a robust 100% Tri8 line (ESC 9), respectively. The IC SD values show
detectable chromosomal imbalances for 10% mixtures and above for both chr8 and chrY, reflecting the sensitivity of our method. Blue
squares indicate the internal controls, green squares (A and B) or bars (C) indicate dilutions below the limit of detection (and are
considered ‘‘normal’’ according to our cutoff level), and red squares (A and B) or bars (C) indicate partial Trisomy 8 (A) or partial Loss of chrY
(B) are considered ‘‘aneuploidy’’ according to our cutoff level. The IC STDEV refers to the interchromosomal SD or IC SD.
Targeting Facility, The Rockefeller University) were thawed and
plated on 9.6 cm2 wells (6-well plate) onto mitotically inactivated
mouse embryonic fibroblasts (MEFs) (Millipore) in a standard
ESC medium (EmbryoMax Dulbecco’s Modified Eagle Medium

[DMEM], High Glucose, Low Bicarbonate without sodium pyruvate [EMD Millipore], supplemented with 15% ESC-approved fetal
bovine serum [FBS, Gibco], EmbryoMax Nucleosides [1003] 1%,
EmbryoMax Penicillin-Streptomycin [1003] 1%, EmbryoMax

Figure 2. Interchromosomal SDs
The IC SD represents the interchromosomal SD of NRQ values between all chromosomes within an mESC line. The confidence level (CL) of
0.0906 was calculated using 11 known, normal mESC lines and can be used as a standardized cutoff line (shown in black) to assess
karyotypes of any cell lines. mESC lines that produced germline animals are highlighted in green, and all show IC SD values even below our
stringent cutoff of 0.0681. The IC STDEV refers to the interchromosomal SD or IC SD.
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Non-Essential Amino Acids [1003] 1%, EmbryoMax L-Glutamine
Solution [1003] 1%, EmbryoMax 2-Mercaptoethanol (1003) 1%,
and ESGRO mLIF Medium Supplement 1000, units/ml [all from
EMD Millipore]). Cells were maintained at 37 C and 5% CO2 in
a humidified incubator. At 90%–95% confluency, the cells were
passaged into a 25 cm2 flask (T-25) on MEFs. At 90%–95% confluency, the cells were trypsinized and transferred into a new T-25
flask without MEFs. After 30 min, the medium containing the cells
was gently removed and plated into a new flask without MEFs.
The MEFs adhere to the flask in about 30 min, whereas the ESCs
require longer time to attach and remain in the suspension.
Thus, a significant number of MEFs can be removed by this differential adhesion step. The MEFs removal protocol was repeated on
the following day to ensure a complete lack of MEFs, which is
crucial to the accuracy of the qPCR karyotyping. 30 min posttrypsinization, the medium containing the ESCs was collected into a
sterile 15 ml centrifuge tube and spun at 1000 rpm for 5 min.
The supernatant was removed, and the pellet was resuspended in
6 ml of lysis buffer (100 ml protocol: 10 mM Tris-HCl [pH 7.5] =
0.5 ml of 2 M, 10 mM EDTA = 2 ml of 0.5 M, 10 mM NaCl =
0.2 ml of 5 M, 0.5% [w/v] Sarkosyl = 0.5 g N-lauroylsarcosine
[Sigma #L-9150]) and 40 ml of proteinase K (200 mg/ml, Fisher
Scientific) and incubated overnight at 55 C. The DNA was precipitated by adding 6 ml of isopropanol and gently inverting
the tube four to five times. The DNA pellet was resuspended in
400 ml of Tris-EDTA buffer (Fisher Scientific), and the tube was
air-dried at 42 C for 1–2 hr. A second 42 C closed-cap incubation
was performed overnight. The gDNA concentrations of all samples
ranged between 55.44 ng/ml (ESC 37) and 1,897.12 ng/ml (ESC 50)
with a median of 316.79 ng/ml and an average 260/280 ratio of
1.90 ± 0.0474. All concentrations are listed in the Table S6.
Genomic ESC DNA was digested with EcoRI (New England Biolabs)
to remove the viscosity of the sample, which is critical for both
the accessibility of the primers and the reproducibility of the
Cq values. None of the amplicons contain EcoRI restriction
sites. Restriction conditions were the following for a total volume
of 100 ml:
1.
2.
3.
4.
5.

gDNA: 3 ml (1 mg)
EcoRI buffer: 10 ml
EcoRI: 2 ml
PCR grade water: 85 ml
Cut for 3 hr at 37 C (no heat inactivation)

SYBR Green I Real-time ESC genomic DNA PCR
Six PCR primer pairs were designed with Primer3 Software
(http://bioinfo.ut.ee/primer3-0.4.0/), in silico validated by
OligoAnalyzer 3.1 (http://www.idtdna.com/analyzer/Applications/
OligoAnalyzer/), and synthesized by Integrated DNA Technologies
with standard desalting purification. The BLAST program from the
NCBI browser (http://blast.ncbi.nlm.nih.gov/) was used for
in silico specificity analysis and primer sequences were submitted
to the RTPrimerDB (http://medgen.ugent.be/rtprimerdb/). Primer
IDs are shown in Table 2). The absence of secondary structures in
the region in which the primers anneal was verified using MFOLD
(http://mfold.rna.albany.edu/?q=mfold). The in silico validation
was followed by an extensive empirical validation. The specificity
of each amplicon was tested based upon melting curve analysis

(single peaks) and gel electrophoresis (Figure S2B). Amplification
efficiencies were calculated based upon the generation of
standard curves using a 2-fold gDNA dilution series (Figure S2A).
The linear dynamic range was five dilutions and standard curve
slopes, PCR efficiencies, r2 values, linear dynamic range and limit
of detection (LOD) for all amplicons analyzed is summarized in Table
2. The qPCR mixture (10 ml) contained 4.25 ml Lightcycler 480 SYBR
Green I Master (Roche Diagnostics), 1.7 ml of each primer (at 10 pM),
0.85 ml of deionized H2O, and 1.5 ml of digested genomic ESC DNA
(i.e., ±15 ng). qPCRs were set up manually using a Matrix Electronic
Multichannel Pipette with 12.5 ml Impact 384 Tips (Thermo Scientific, cat#7421), and the reactions were carried out in white 384-well
plates (E&K Scientific, cat# 486384) covered with ThermaSeal optical
covers (Excel Scientific, cat# TSS-RTQ-100). All plates were spun
down prior to covering to eliminate air bubbles. This step is also critical for the reproducibility of the Cq values. Reaction were run on a
Roche Lightcycler 480 using the following cycling conditions: an
initial denaturation step at 95 C for 5 min, followed by a 35 cycle
amplification step of 95 C for 20 s, 60 C for 15 s, and 72 C for 15 s
and a final cooling step at 40 C for 30 s. PCR products were detected
in the presence of SYBR Green, and the Cq value for the no template
controls was >30 for all primer sets.

Data analysis
Quantification cycle values were extracted using the Lightcycler
480 software (version 1.5.0 SP4) using the second derivative
maximum algorithm. Further data analysis was carried out in Excel
(see Tables S3, S4 and S5) on the exported data as follows:
To calculate the normalized relative quantities (NRQs or 2-ddCq
values) for each sample within each gene of interest:
1. Calculate the intertriplicate difference in Cq values (dCqtriplicates).
Samples with jdCqjtriplicates >0.2206 should be removed from the
analysis and repeated.
2. Calculate the average Cq value per sample per gene using the triplicate Cq values.
3. Calculate the difference in Cq between the gene of interest (GOI)
and the reference gene on chr7, i.e., dCq(GOI-chr7).
4. Calculate for each gene the difference between the dCq (GOI-chr7) of
each sample and the dCq (GOI-chr7) of the chosen calibrator (i.e.,
ddCq). In case of multiple calibrators, repeat the calculation for
each calibrator separately.
5. Calculate within each chromosome the 2ddCq for each sample
using the previously obtained ddCq values. This is the NRQ value.
6. In case of using multiple calibrators, calculate the mean 2ddCq value
for each sample by averaging all NRQ values obtained using the
different calibrators.
7. This average NRQ value indicates the fold change in dosage of the
GOI as compared to the ‘‘normal’’ calibrator(s).
8. Calculate the normalization factor using the NRQ values from chrX
(NFX). The NFX is obtained by subtracting the NRQ (X) from 1 for
each sample within chrX. The data are normalized by adding the
NFX to the NRQ of each sample within each gene of interest. This
sum will yield a NRQ of 1 for all samples within chrX.
9. Repeat steps 3–8 for the other endogenous control chrX and
normalize the data using the chr7.
10. Calculate the average NRQ for each sample within each GOI using
both NRQ values.
11. This average NRQ value indicates the fold change in dosage of the
GOI as compared to the ‘‘normal’’ calibrator(s) and normalized
against two stable chromosomes, i.e., chr7 and chrX (i.e., the
normalized relative quantity or NRQ).
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12. This value may be multiplied by 2 to obtain the absolute copy
number for the autosomes or X in case of female ESCs.

To calculate the interchromosomal SD (IC SD):
1. Calculate the IC SD per sample by determining the SD between the
NRQs for each amplicon of the five different chromosomes within
each ESC clone. The NRQ values for chr7 and chrX are 1 and are
included in the IC SD calculation.
2. When the IC SD is greater than 0.0681, our 67% stringent confidence
level (CL), samples may be considered abnormal. If the IC SD is
greater than our 95% CL of 0.0906, then samples should be considered abnormal. The corresponding NRQ can subsequently be used
to evaluate which of the chromosomes is aneuploid.

SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and six tables and
can be found with this article online at http://dx.doi.org/10.1016/
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